Sex-Specific Platelet Activation Through Protease-Activated Receptors Reverses in Myocardial Infarction. Issue 1 (January 2021)
- Record Type:
- Journal Article
- Title:
- Sex-Specific Platelet Activation Through Protease-Activated Receptors Reverses in Myocardial Infarction. Issue 1 (January 2021)
- Main Title:
- Sex-Specific Platelet Activation Through Protease-Activated Receptors Reverses in Myocardial Infarction
- Authors:
- Soo Kim, Beom
Auerbach, David S.
Sadhra, Hamza
Godwin, Matthew
Bhandari, Rohan
Ling, Frederick S.
Mohan, Amy
Yule, David I.
Wagner, Larry
Rich, David Q.
Ture, Sara
Morrell, Craig N.
Timpanaro-Perrotta, Livia
Younis, Arwa
Goldenberg, Ilan
Cameron, Scott J. - Abstract:
- Abstract : Objective: The platelet phenotype in certain patients and clinical contexts may differ from healthy conditions. We evaluated platelet activation through specific receptors in healthy men and women, comparing this to patients presenting with ST-segment-elevation myocardial infarction and non-ST-segment-elevation myocardial infarction. Approach and Results: We identified independent predictors of platelet activation through certain receptors and a murine MI model further explored these findings. Platelets from healthy women and female mice are more reactive through PARs (protease-activated receptors) compared with platelets from men and male mice. Multivariate regression analyses revealed male sex and non-ST-segment-elevation myocardial infarction as independent predictors of enhanced PAR1 activation in human platelets. Platelet PAR1 signaling decreased in women and increased in men during MI which was the opposite of what was observed during healthy conditions. Similarly, in mice, thrombin-mediated platelet activation was greater in healthy females compared with males, and lesser in females compared with males at the time of MI. Conclusions: Sex-specific signaling in platelets seems to be a cross-species phenomenon. The divergent platelet phenotype in males and females at the time of MI suggests a sex-specific antiplatelet drug regimen should be prospectively evaluated. Abstract : Supplemental Digital Content is available in the text.
- Is Part Of:
- Arteriosclerosis, thrombosis, and vascular biology. Volume 41:Issue 1(2021)
- Journal:
- Arteriosclerosis, thrombosis, and vascular biology
- Issue:
- Volume 41:Issue 1(2021)
- Issue Display:
- Volume 41, Issue 1 (2021)
- Year:
- 2021
- Volume:
- 41
- Issue:
- 1
- Issue Sort Value:
- 2021-0041-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-01
- Subjects:
- female -- myocardial infarction -- platelet activation -- regression analysis -- thrombin
Arteriosclerosis -- Periodicals
Thrombosis -- Periodicals
Blood-vessels -- Pathophysiology -- Periodicals
Electronic journals
616.13 - Journal URLs:
- http://atvb.ahajournals.org/contents-by-date.0.shtml ↗
http://journals.lww.com ↗ - DOI:
- 10.1161/ATVBAHA.120.315033 ↗
- Languages:
- English
- ISSNs:
- 1079-5642
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1733.670000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 21928.xml